ACAAI: Many Anaphylaxis Protocols Are Incomplete, Outdated

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 25, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Oct. 25, 2024 -- Many anaphylaxis protocols are incomplete and/or outdated, and there is a need for patient education regarding treatment of anaphylaxis, according to two studies presented at the annual meeting of the American College of Allergy, Asthma & Immunology, held from Oct. 24 to 28 in Boston.

Carly Gunderson, D.O., from the Baylor College of Medicine in San Antonio, and colleagues reviewed allergic reaction and/or anaphylaxis protocols for 30 states with mandatory or model state-wide Advanced Cardiac Life Support protocols. The researchers found that only 50 and 40 percent of the states included gastrointestinal symptoms and neurological manifestations, respectively, in the definition of anaphylaxis. A two-organ system definition was used by 47 percent. All of the protocols recommended diphenhydramine and epinephrine for anaphylactic reactions. If respiratory symptoms were present, 90, 73, and 60 percent recommended albuterol, intravenous fluids, and steroids, respectively. In 97 percent of protocols, epinephrine was the first-line recommendation for anaphylaxis.

Joni Chow, D.O., also from the Baylor College of Medicine, and colleagues surveyed 96 patients/caregivers in the waiting room of an allergy clinic to assess knowledge of anaphylaxis. The researchers found that 95.8 percent of respondents were prescribed epinephrine. Overall, 14 percent correctly identified symptoms requiring epinephrine, although 73 percent agreed or strongly agreed with feeling comfortable with recognizing anaphylaxis symptoms. Almost one-quarter (23.7 percent) would treat with antihistamine first during an anaphylactic episode, although 85 percent stated that antihistamines do not prevent the need for epinephrine.

"The results demonstrate the need for better education of allergy patients to recognize and treat anaphylaxis appropriately," Chow said in a statement.

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-26 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords